Corvus Pharmaceuticals (CRVS) Leases (2022 - 2025)
Historic Leases for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $927000.0.
- Corvus Pharmaceuticals' Leases rose 20900.0% to $927000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $927000.0, marking a year-over-year increase of 20900.0%. This contributed to the annual value of $1.2 million for FY2024, which is 243.69% up from last year.
- Corvus Pharmaceuticals' Leases amounted to $927000.0 in Q3 2025, which was up 20900.0% from $1.0 million recorded in Q2 2025.
- Corvus Pharmaceuticals' Leases' 5-year high stood at $3.0 million during Q1 2022, with a 5-year trough of $300000.0 in Q3 2024.
- Its 4-year average for Leases is $1.5 million, with a median of $1.2 million in 2024.
- Its Leases has fluctuated over the past 5 years, first tumbled by 7891.78% in 2024, then surged by 20900.0% in 2025.
- Over the past 4 years, Corvus Pharmaceuticals' Leases (Quarter) stood at $2.2 million in 2022, then plummeted by 48.17% to $1.1 million in 2023, then increased by 2.44% to $1.2 million in 2024, then dropped by 21.24% to $927000.0 in 2025.
- Its last three reported values are $927000.0 in Q3 2025, $1.0 million for Q2 2025, and $1.1 million during Q1 2025.